MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

    C. García-Sánchez, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Pagonabarraga-Mora, J. Marin-Lahoz, J. Pérez-Perez, A. Campolongo, C. izquierdo, H. Bejr-Kasen, I. Aracil, S. Martínez -Horta, A. Horta, M. Botí, E. Marin, J. Kulisevsky (Barcelona, Spain)

    Objective: To study the performance of PD-CRS before and after STN-DBS and compare their results with other recognized cognitive scales. Background: Deep brain stimulation of…
  • 2018 International Congress

    Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats

    S. Singh (Moga, India)

    Objective: (1) Curcumin is well tolerated curcuminoid used as supplement for various disorders but problem is its low oral bioavailability. (2) Piperine is combined to…
  • 2018 International Congress

    The relationship between asymmetric dopamine loss and cognition in early Parkinson’s disease patients from PPMI study

    R. Biundo, E. Fiorenzato, L. Weis, A. Antonini (Venice, Italy)

    Objective: To explore the role of motor asymmetry on cognition in early stage Parkinson’s disease (PD). Background: PD is characterized by asymmetric motor onset which…
  • 2018 International Congress

    Reproductive factors influence on cognitive function of Parkinson’s disease in female patients-from a cross-sectional study

    Y. Wu, H. Liu, R.W. Ou, Q.Q. Wei, H.F. Shang (Chengdu, People’s Republic of China)

    Objective: To explore the relationship between the female reproductive factors and cognitive decline/dementia with PD Background: Cognitive dysfunction was the common non-motor features of Parkinson’s…
  • 2018 International Congress

    Clinical predictors of screen-defined dementia in early Parkinson’s

    F. Baig, M. Lawton, M. Rolinski, C. Ruffmann, T. Barber, J. Klein, C. Lo, Y. Ben-Shlomo, M. Hu (Oxford, United Kingdom)

    Objective: Predicting early dementia in Parkinson’s disease (PD) has important implications for individual prognosis, designing clinical trials and targeting novel treatments, but there remains a…
  • 2018 International Congress

    A promising model for cognitive dysfunction in Parkinson’s Disease by AAV-mediated alpha-synuclein overexpression in hippocampus

    E. Cinar, G. Yalcin-Cakmakli, E. Saka, A. Ulusoy, B. Tel, B. Elibol (Ankara, Turkey)

    Objective: Our aim is to model cognitive dysfunction of Parkinson's disease (PD) together with motor deficits by targeted overexpression of alpha-synuclein (a-syn) in bilateral dentate…
  • 2018 International Congress

    Subcortical and Cortical 123I-FP-CIT binding deficits and mild cognitive impairment in Parkinson’s disease

    A. Pilotto, F. Schiano DiCola, E. Premi, V. Garibotto, A. Scalvini, R. Turrone, R. Grasso, B. Bigni, S. Gipponi, B. Paghera, MC. Rizzetti, b. Borroni, A. Padovani (Brescia, Italy)

    Objective: The objective of the study was to evaluate the relationship between basal ganglia and cortical 123I-FP-CIT binding and early cognitive deficits in PD. Background:…
  • 2018 International Congress

    Hypertriglyceridemia is associated with Parkinson disease mild cognitive impairment (PD-MCI)

    S. Ng, KY. Tay, X. Huang, NSY. Chia, S. Archaryya, F. Setiawan, ZH. Lu, J. Tan, YL. Ng, MC. Wen, A. Ng, W. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: Our study aimed to characterise Parkinson disease (PD) mild cognitive impairment (PD-MCI) in early PD and to identify biomarkers associated with PD-MCI. Background: Approximately…
  • 2018 International Congress

    Opposite effects of dopamine on specific NoGo perfomance in young and late onset Parkinson’s disease and the relationship to nigrostriatal degeneration

    D. Kübler, H. Schroll, U. Scheller, R. Buchert, A. Kühn (Berlin, Germany)

    Objective: To investigate inhibitory control under dopamine (DA) in Parkinson’s disease (PD). Background: The pattern of degeneration in PD as well as side effects of…
  • 2018 International Congress

    The Portuguese Version of Montreal Cognitive Assessment as a screening test comparing Vascular Parkinsonism and Parkinson´s Disease in a hospital cross-section study

    A. Velon, M. Mendes, R. Almendra, A. Almeida, M. Correia, C. (Vila Real, Portugal)

    Objective: Compare cognitive function between Vascular Parkinsonism (VaP) and Parkinson´s Disease (PD) patients. Background: Portuguese version of Montreal Cognitive Assessment (MoCA) is a validated screening…
  • « Previous Page
  • 1
  • …
  • 1316
  • 1317
  • 1318
  • 1319
  • 1320
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley